KR890004686A - 서방성 에토돌락 - Google Patents
서방성 에토돌락 Download PDFInfo
- Publication number
- KR890004686A KR890004686A KR1019880012298A KR880012298A KR890004686A KR 890004686 A KR890004686 A KR 890004686A KR 1019880012298 A KR1019880012298 A KR 1019880012298A KR 880012298 A KR880012298 A KR 880012298A KR 890004686 A KR890004686 A KR 890004686A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- base material
- carrier base
- sustained release
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1 내지 3도는 본 발명의 서방성 투여형의 에토돌락의 용해도를 도시한 것이다.
Claims (4)
- 담체 기본물질, 에토돌락 및 방출속도 조절제를 혼합 함유하고 투여시에 규칙적이고 지속적인 방출 패턴을 갖는 고체 단위 투여형으로 성형 및 압축되며, 이 때 담체 기본 물질은, 하이드록시프로폭실 함량이 약 7.0중량% 내지 8.6중량%이고, 메톡실 함량이 약 19중량% 내지 24중량%이며 평균 분자량 50,000 미만인 하이드록시프로필메틸 셀룰로오스가 15 내지 28중량%의 에틸셀룰로오스 혼합물과 혼합된 물질이며 방출속도 조절제는 유효량의 생리적으로 허용되는 완충산, 완충산염 또는 이의 혼합물임을 특징으로 하는 서방성 조성물.
- 제1항에 있어서, 방출 속도 조절제가 이염기성 인산나트륨인 조성물.
- 제1항에 있어서, 담체 기본 물질이 고체 단위 투여형의 약 18중량% 내지 약 30중량%의 범위 이내인 조성물.
- 제1항에 있어서, 하이드록시프로필메틸셀룰로오스 중의 하이드록시프로폭실 함량이 7.5 내지 8.0중량%인 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10050187A | 1987-09-24 | 1987-09-24 | |
US100,501 | 1987-09-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890004686A true KR890004686A (ko) | 1989-05-09 |
KR960009410B1 KR960009410B1 (en) | 1996-07-19 |
Family
ID=22280080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR88012298A KR960009410B1 (en) | 1987-09-24 | 1988-09-23 | Sustained release etodolac |
Country Status (21)
Country | Link |
---|---|
US (1) | US4966768A (ko) |
EP (1) | EP0309157B1 (ko) |
JP (1) | JP2879061B2 (ko) |
KR (1) | KR960009410B1 (ko) |
AT (1) | ATE62132T1 (ko) |
AU (1) | AU613663B2 (ko) |
CA (1) | CA1318600C (ko) |
DE (1) | DE3862272D1 (ko) |
DK (1) | DK168421B1 (ko) |
ES (1) | ES2021838B3 (ko) |
FI (1) | FI89005C (ko) |
GB (1) | GB2209940B (ko) |
GR (1) | GR3001739T3 (ko) |
HK (1) | HK41994A (ko) |
HU (1) | HU200920B (ko) |
IE (1) | IE60311B1 (ko) |
IL (1) | IL87757A (ko) |
MX (1) | MX171463B (ko) |
PH (1) | PH26146A (ko) |
PT (1) | PT88564B (ko) |
ZA (1) | ZA887162B (ko) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993017673A1 (en) * | 1992-03-03 | 1993-09-16 | Top Gold Pty., Limited | Sustained release analgesics |
US5314697A (en) * | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US5419917A (en) * | 1994-02-14 | 1995-05-30 | Andrx Pharmaceuticals, Inc. | Controlled release hydrogel formulation |
PE10898A1 (es) * | 1995-06-13 | 1998-03-20 | American Home Prod | Formulaciones orales de etodolac s (+)- |
PE57198A1 (es) | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
US20060068001A1 (en) * | 1996-03-25 | 2006-03-30 | Wyeth | Extended release formulation |
US20030215507A1 (en) * | 1996-03-25 | 2003-11-20 | Wyeth | Extended release formulation |
US6274171B1 (en) | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
US6251430B1 (en) | 1998-02-04 | 2001-06-26 | Guohua Zhang | Water insoluble polymer based sustained release formulation |
US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
US6106862A (en) * | 1998-08-13 | 2000-08-22 | Andrx Corporation | Once daily analgesic tablet |
JP2002531491A (ja) | 1998-12-11 | 2002-09-24 | ノストラム・ファーマスーティカルズ・インコーポレイテッド | ヒドロコロイドおよびセルロースエーテルを含む持続放出性錠剤 |
US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
US7151100B1 (en) * | 1999-07-23 | 2006-12-19 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
IN190974B (ko) * | 1999-09-10 | 2003-09-06 | Ranbaxy Lab Ltd | |
US20040152672A1 (en) * | 2000-08-09 | 2004-08-05 | Carson Dennis A. | Indole compounds useful for the treatment of cancer |
ES2398910T3 (es) * | 2001-09-28 | 2013-03-22 | Tntgamble, Inc. | Sistema de aporte para componentes biológicos |
US20070098784A1 (en) * | 2001-09-28 | 2007-05-03 | Nutraceutix, Inc. | Delivery system for biological component |
SI1443917T1 (sl) * | 2001-11-07 | 2006-06-30 | Synthon Bv | Tablete tamsulozina |
IL146462A (en) * | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
ES2285088T3 (es) * | 2002-01-09 | 2007-11-16 | Ucb Farchim S.A. | Composiciones farmaceuticas de liberacion modificada. |
EP2266590A3 (en) | 2002-02-22 | 2011-04-20 | Shire LLC | Active agent delivery sytems and methods for protecting and administering active agents |
WO2004026116A2 (en) * | 2002-09-19 | 2004-04-01 | The Regents Of The University Of California | Use of etodoclac to treat hyperplasia |
US6703044B1 (en) | 2002-10-25 | 2004-03-09 | Dexcel Pharma Tech, Ltd | Venlafaxine formulations |
US7018658B2 (en) * | 2002-11-14 | 2006-03-28 | Synthon Bv | Pharmaceutical pellets comprising tamsulosin |
US20040185097A1 (en) * | 2003-01-31 | 2004-09-23 | Glenmark Pharmaceuticals Ltd. | Controlled release modifying complex and pharmaceutical compositions thereof |
US8802139B2 (en) | 2003-06-26 | 2014-08-12 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US20050106253A1 (en) * | 2003-11-13 | 2005-05-19 | Platteeuw Johannes J. | Pharmaceutical pellets comprising tamsulosin |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US9561188B2 (en) | 2006-04-03 | 2017-02-07 | Intellipharmaceutics Corporation | Controlled release delivery device comprising an organosol coat |
CA2648495C (en) * | 2006-04-26 | 2016-07-05 | Alphapharm Pty Ltd | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
EP2026766A1 (en) | 2006-05-17 | 2009-02-25 | Synthon B.V. | Tablet composition with a prolonged release of tamsulosin |
US8465770B2 (en) | 2008-12-24 | 2013-06-18 | Synthon Bv | Low dose controlled release tablet |
TR200908308A1 (tr) | 2010-01-18 | 2011-08-22 | Turgut İlaçlari A.Ş. | Etodolak içeren sürekli salım tablet formulasyonu |
CN102485215B (zh) * | 2010-12-03 | 2013-05-15 | 沈阳药科大学 | 依托度酸定时释药微丸制剂及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3939178A (en) * | 1971-06-01 | 1976-02-17 | American Home Products Corporation | Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles |
GB1468172A (en) * | 1973-03-28 | 1977-03-23 | Benzon As Alfred | Oral drug preparations |
US3954959A (en) * | 1973-03-28 | 1976-05-04 | A/S Alfred Benzon | Oral drug preparations |
US4309406A (en) * | 1979-07-10 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4309404A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4309405A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
US4533551A (en) * | 1984-02-17 | 1985-08-06 | American Home Products Corporation | Method of treating arthritis with etodolac |
US4657757A (en) * | 1985-03-29 | 1987-04-14 | Schering Corporation | Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate |
-
1988
- 1988-09-07 IE IE270988A patent/IE60311B1/en not_active IP Right Cessation
- 1988-09-09 CA CA000576957A patent/CA1318600C/en not_active Expired - Lifetime
- 1988-09-13 AU AU22153/88A patent/AU613663B2/en not_active Expired
- 1988-09-15 FI FI884245A patent/FI89005C/fi not_active IP Right Cessation
- 1988-09-15 IL IL87757A patent/IL87757A/xx active Protection Beyond IP Right Term
- 1988-09-16 GB GB8821749A patent/GB2209940B/en not_active Expired - Lifetime
- 1988-09-16 DE DE8888308564T patent/DE3862272D1/de not_active Expired - Lifetime
- 1988-09-16 AT AT88308564T patent/ATE62132T1/de not_active IP Right Cessation
- 1988-09-16 EP EP88308564A patent/EP0309157B1/en not_active Expired - Lifetime
- 1988-09-16 ES ES88308564T patent/ES2021838B3/es not_active Expired - Lifetime
- 1988-09-17 JP JP63233366A patent/JP2879061B2/ja not_active Expired - Lifetime
- 1988-09-21 PT PT88564A patent/PT88564B/pt not_active IP Right Cessation
- 1988-09-21 MX MX013091A patent/MX171463B/es unknown
- 1988-09-23 DK DK531088A patent/DK168421B1/da not_active IP Right Cessation
- 1988-09-23 ZA ZA887162A patent/ZA887162B/xx unknown
- 1988-09-23 KR KR88012298A patent/KR960009410B1/ko not_active IP Right Cessation
- 1988-09-23 HU HU884992A patent/HU200920B/hu unknown
- 1988-09-23 PH PH37584A patent/PH26146A/en unknown
- 1988-11-07 US US07/268,646 patent/US4966768A/en not_active Expired - Lifetime
-
1991
- 1991-04-04 GR GR91400364T patent/GR3001739T3/el unknown
-
1994
- 1994-04-28 HK HK41994A patent/HK41994A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2021838B3 (es) | 1991-11-16 |
HUT50631A (en) | 1990-03-28 |
FI884245A0 (fi) | 1988-09-15 |
HK41994A (en) | 1994-05-06 |
GB2209940B (en) | 1991-08-14 |
US4966768A (en) | 1990-10-30 |
IL87757A0 (en) | 1989-02-28 |
FI89005C (fi) | 1993-08-10 |
HU200920B (en) | 1990-09-28 |
EP0309157A1 (en) | 1989-03-29 |
DK531088A (da) | 1989-03-25 |
GB2209940A (en) | 1989-06-01 |
JPH02270820A (ja) | 1990-11-05 |
DK531088D0 (da) | 1988-09-23 |
GB8821749D0 (en) | 1988-10-19 |
DK168421B1 (da) | 1994-03-28 |
FI884245A (fi) | 1989-03-25 |
KR960009410B1 (en) | 1996-07-19 |
IE882709L (en) | 1989-03-24 |
DE3862272D1 (de) | 1991-05-08 |
PH26146A (en) | 1992-03-18 |
PT88564B (pt) | 1992-11-30 |
GR3001739T3 (en) | 1992-11-23 |
JP2879061B2 (ja) | 1999-04-05 |
IE60311B1 (en) | 1994-06-29 |
AU613663B2 (en) | 1991-08-08 |
MX171463B (es) | 1993-10-28 |
PT88564A (pt) | 1988-10-01 |
ATE62132T1 (de) | 1991-04-15 |
AU2215388A (en) | 1989-05-11 |
IL87757A (en) | 1992-06-21 |
ZA887162B (en) | 1990-05-30 |
CA1318600C (en) | 1993-06-01 |
EP0309157B1 (en) | 1991-04-03 |
FI89005B (fi) | 1993-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890004686A (ko) | 서방성 에토돌락 | |
ES8402155A1 (es) | Un metodo para producir formas posologicas unitarias solidas que al administrarse siguen una pauta de liberacion regular y prolongada. | |
YU46701B (sh) | Postupak u za dobijanje osnovnog nosećeg materijala za dozne oblike lekova sa produženim izdvajanjem aktivne supstance | |
ES8500740A1 (es) | Un metodo para la preparacion de una forma posologica unitaria solida, terapeuticamente activa, con pauta de liberacion regular y prolongada al ser administrada. | |
SE8303531D0 (sv) | Farmaceutisk komposition | |
CA2247191A1 (en) | Powdery composition for nasal administration | |
FR2613224B1 (fr) | Forme posologique bicouche a liberation prolongee | |
ES8802206A1 (es) | Procedimiento para la preparacion de microparticulas que permiten la liberacion prolongada de una substancia biologicameente activa. | |
ES8602418A1 (es) | Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona. | |
GB1286949A (en) | Polymer-containing bile acid-fixing and triglyceride-fixing compositions for oral administration | |
ES8608288A1 (es) | Un procedimiento para producir una tableta de goma de mascar | |
ID22763A (id) | Komposisi penstabil tibolon | |
KR920002155A (ko) | 슈크랄페이트(Sucralfate) 저작성 타블렛 | |
KR910011241A (ko) | 정제로 직접 압착 가능한 약제학적 분말 조성물을 제조하기 위한 분무 건조법 | |
KR890006235A (ko) | 피페리디노알칸올용 제약 조성물 | |
ES8200678A1 (es) | Un procedimiento para la produccion de 10-(4-piperidinil)-10, 11-dihidro-dibenzo b,f 1,4 oxarepinas; tiazepinas y diaze-pinas. | |
KR900009060A (ko) | 트리메부틴 기재 서방형 조성물 및 그 제조 방법 | |
AU618896B2 (en) | Stable solutions of rebeccamycin analog and preparation thereof | |
KR900015732A (ko) | 경구용 제제 | |
KR890001559A (ko) | 트라피딜을 함유하는 제약 조성물, 그의 제조방법 및 관련된 치료 용도 | |
GB1440832A (en) | Pharmaceutical preparation comprising antibiotics | |
SE8106498L (sv) | Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma | |
ES8401483A1 (es) | Procedimiento para preparar nuevas furobenzazepinas. | |
KR850008097A (ko) | 경구투여를 위한 고형의 서방성 제제방법 및 캅셀 제제방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
J121 | Written withdrawal of request for trial | ||
J206 | Request for trial to confirm the scope of a patent right | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20080318 Effective date: 20080827 |
|
FPAY | Annual fee payment |
Payment date: 20100630 Year of fee payment: 15 |
|
EXPY | Expiration of term |